25 September 2019 - Congress was gavelled back into session this month with unprecedented momentum behind legislative efforts to hold Big Pharma accountable and lower prescription drug prices.

An array of key factors are aligned that make now the time that lawmakers simply must act to get these, and additional, solutions in the end zone.

First, even in a deeply divided political climate, there continues to be true bipartisan cooperation, commitment and a shared vision on market-based solutions to lower drug prices.

Read The Hill article